NCT05905185View on ClinicalTrials.gov

Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

January 21, 2022

Conditions
Obesity
Interventions
DRUG

Tocotrienol-rich fraction vitamin E (TRF)

The 50 mg of vitamin E isomers in the TRF included 17.1 mg of α-tocopherol ,18.28 mg of α- tocotrienol, 2.02 mg of β-tocotrienol, 22.3 mg of γ-tocotrienol and 7.4 mg of δ-tocotrienol.

DRUG

Placebo

50mg of Placebo

Trial Locations (1)

Unknown

National University Of Malaysia, Kuala Lumpur

All Listed Sponsors
lead

National University of Malaysia

OTHER

NCT05905185 - Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity | Biotech Hunter | Biotech Hunter